Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1989 May;65(763):275–281. doi: 10.1136/pgmj.65.763.275

Apolipoproteins in lipid transport, an impressionist view.

D W Erkelens 1
PMCID: PMC2429321  PMID: 2692008

Full text

PDF
275

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biesbroeck R., Oram J. F., Albers J. J., Bierman E. L. Specific high-affinity binding of high density lipoproteins to cultured human skin fibroblasts and arterial smooth muscle cells. J Clin Invest. 1983 Mar;71(3):525–539. doi: 10.1172/JCI110797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Breckenridge W. C., Little J. A., Steiner G., Chow A., Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med. 1978 Jun 8;298(23):1265–1273. doi: 10.1056/NEJM197806082982301. [DOI] [PubMed] [Google Scholar]
  3. Brown M. S., Goldstein J. L. Plasma lipoproteins: teaching old dogmas new tricks. Nature. 1987 Nov 12;330(6144):113–114. doi: 10.1038/330113a0. [DOI] [PubMed] [Google Scholar]
  4. Brown M. S., Kovanen P. T., Goldstein J. L. Regulation of plasma cholesterol by lipoprotein receptors. Science. 1981 May 8;212(4495):628–635. doi: 10.1126/science.6261329. [DOI] [PubMed] [Google Scholar]
  5. Brunzell J. D., Albers J. J., Chait A., Grundy S. M., Groszek E., McDonald G. B. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res. 1983 Feb;24(2):147–155. [PubMed] [Google Scholar]
  6. Brunzell J. D., Hazzard W. R., Porte D., Jr, Bierman E. L. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest. 1973 Jul;52(7):1578–1585. doi: 10.1172/JCI107334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dullaart R. P., Groener J. E., Erkelens D. W. Effect of the composition of very low and low density lipoproteins on the rate of cholesterylester transfer from high density lipoproteins in man, studied in vitro. Eur J Clin Invest. 1987 Jun;17(3):241–248. doi: 10.1111/j.1365-2362.1987.tb01243.x. [DOI] [PubMed] [Google Scholar]
  8. Dullaart R. P., Speelberg B., Schuurman H. J., Milne R. W., Havekes L. M., Marcel Y. L., Geuze H. J., Hulshof M. M., Erkelens D. W. Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia. J Clin Invest. 1986 Nov;78(5):1397–1404. doi: 10.1172/JCI112727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Erkelens D. W., Brunzell J. D., Bierman E. L. Availability of apolipoprotein CII in relation to the maximal removal capacity for an infused triglyceride emulsion in man. Metabolism. 1979 May;28(5):495–501. doi: 10.1016/0026-0495(79)90188-4. [DOI] [PubMed] [Google Scholar]
  10. Erkelens D. W., Chen C., Mitchell C. D., Glomset J. A. Studies of the interaction between apolipoproteins A and C and triacylglycerol-rich particles. Biochim Biophys Acta. 1981 Aug 24;665(2):221–233. doi: 10.1016/0005-2760(81)90006-0. [DOI] [PubMed] [Google Scholar]
  11. Erkelens D. W., Mocking J. A. The CII/CIII ratio of transferable apolipoprotein in primary and secondary hypertriglyceridemia. Clin Chim Acta. 1982 May 6;121(1):59–65. doi: 10.1016/0009-8981(82)90211-x. [DOI] [PubMed] [Google Scholar]
  12. Erkelens D. W., Mocking J. A. The effect of apolipoprotein A on in vitro apolipoprotein C binding and in vivo removal of artificial triacylglycerol-rich particles. Metabolism. 1985 Mar;34(3):222–226. doi: 10.1016/0026-0495(85)90004-6. [DOI] [PubMed] [Google Scholar]
  13. Fielding C. J., Fielding P. E. Chylomicron protein content and the rate of lipoprotein lipase activity. J Lipid Res. 1976 Jul;17(4):419–423. [PubMed] [Google Scholar]
  14. Gaubatz J. W., Heideman C., Gotto A. M., Jr, Morrisett J. D., Dahlen G. H. Human plasma lipoprotein [a]. Structural properties. J Biol Chem. 1983 Apr 10;258(7):4582–4589. [PubMed] [Google Scholar]
  15. Ghiselli G., Schaefer E. J., Gascon P., Breser H. B., Jr Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science. 1981 Dec 11;214(4526):1239–1241. doi: 10.1126/science.6795720. [DOI] [PubMed] [Google Scholar]
  16. Glomset J. A. Physiological role of lecithin-cholesterol acyltransferase. Am J Clin Nutr. 1970 Aug;23(8):1129–1136. doi: 10.1093/ajcn/23.8.1129. [DOI] [PubMed] [Google Scholar]
  17. Glomset J. A. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968 Mar;9(2):155–167. [PubMed] [Google Scholar]
  18. Gofman J. W., Young W., Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation. 1966 Oct;34(4):679–697. doi: 10.1161/01.cir.34.4.679. [DOI] [PubMed] [Google Scholar]
  19. Goldstein J. L., Brown M. S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897–930. doi: 10.1146/annurev.bi.46.070177.004341. [DOI] [PubMed] [Google Scholar]
  20. Goldstein J. L., Schrott H. G., Hazzard W. R., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973 Jul;52(7):1544–1568. doi: 10.1172/JCI107332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Groener J. E., Van Rozen A. J., Erkelens D. W. Cholesteryl ester transfer activity. Localization and role in distribution of cholesteryl ester among lipoproteins in man. Atherosclerosis. 1984 Mar;50(3):261–271. doi: 10.1016/0021-9150(84)90074-1. [DOI] [PubMed] [Google Scholar]
  22. HAVEL R. J., GORDON R. S., Jr Idiopathic hyperlipemia: metabolic studies in an affected family. J Clin Invest. 1960 Dec;39:1777–1790. doi: 10.1172/JCI104202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ha Y. C., Barter P. J. Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp Biochem Physiol B. 1982;71(2):265–269. doi: 10.1016/0305-0491(82)90252-8. [DOI] [PubMed] [Google Scholar]
  24. Havekes L. M., de Knijff P., Beisiegel U., Havinga J., Smit M., Klasen E. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res. 1987 Apr;28(4):455–463. [PubMed] [Google Scholar]
  25. Hui D. Y., Innerarity T. L., Milne R. W., Marcel Y. L., Mahley R. W. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48. J Biol Chem. 1984 Dec 25;259(24):15060–15068. [PubMed] [Google Scholar]
  26. Jansen H., Hülsmann W. C. Enzymology and physiological role of hepatic lipase. Biochem Soc Trans. 1985 Feb;13(1):24–26. doi: 10.1042/bst0130024. [DOI] [PubMed] [Google Scholar]
  27. Kane J. P., Hardman D. A., Paulus H. E. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci U S A. 1980 May;77(5):2465–2469. doi: 10.1073/pnas.77.5.2465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Levy E., Marcel Y., Deckelbaum R. J., Milne R., Lepage G., Seidman E., Bendayan M., Roy C. C. Intestinal apoB synthesis, lipids, and lipoproteins in chylomicron retention disease. J Lipid Res. 1987 Nov;28(11):1263–1274. [PubMed] [Google Scholar]
  29. Mahley R. W., Hui D. Y., Innerarity T. L., Weisgraber K. H. Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors. J Clin Invest. 1981 Nov;68(5):1197–1206. doi: 10.1172/JCI110365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Malloy M. J., Kane J. P., Hardman D. A., Hamilton R. L., Dalal K. B. Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein. J Clin Invest. 1981 May;67(5):1441–1450. doi: 10.1172/JCI110173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Miller N. E., Rao S. N., Alaupovic P., Noble N., Slack J., Brunzell J. D., Lewis B. Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest. 1981 Feb;11(1):69–76. doi: 10.1111/j.1365-2362.1981.tb01768.x. [DOI] [PubMed] [Google Scholar]
  32. Small D. M. George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry. Arteriosclerosis. 1988 Mar-Apr;8(2):103–129. doi: 10.1161/01.atv.8.2.103. [DOI] [PubMed] [Google Scholar]
  33. Sniderman A. D., Wolfson C., Teng B., Franklin F. A., Bachorik P. S., Kwiterovich P. O., Jr Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med. 1982 Dec;97(6):833–839. doi: 10.7326/0003-4819-97-6-833. [DOI] [PubMed] [Google Scholar]
  34. Son Y. S., Zilversmit D. B. Purification and characterization of human plasma proteins that inhibit lipid transfer activities. Biochim Biophys Acta. 1984 Oct 4;795(3):473–480. doi: 10.1016/0005-2760(84)90175-9. [DOI] [PubMed] [Google Scholar]
  35. Takagi Y., Dyer C. A., Curtiss L. K. Platelet-enhanced apolipoprotein E production by human macrophages: a possible role in atherosclerosis. J Lipid Res. 1988 Jul;29(7):859–867. [PubMed] [Google Scholar]
  36. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J. 1987 Feb;113(2 Pt 2):433–440. doi: 10.1016/0002-8703(87)90610-7. [DOI] [PubMed] [Google Scholar]
  37. Utermann G., Hees M., Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature. 1977 Oct 13;269(5629):604–607. doi: 10.1038/269604a0. [DOI] [PubMed] [Google Scholar]
  38. Utermann G., Vogelberg K. H., Steinmetz A., Schoenborn W., Pruin N., Jaeschke M., Hees M., Canzler H. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet. 1979 Jan;15(1):37–62. [PubMed] [Google Scholar]
  39. Van Berkel T. J., Kruijt J. K., Scheek L. M., Groot P. H. Effect of apolipoproteins E and C-III on the interaction of chylomicrons with parenchymal and non-parenchymal cells from rat liver. Biochem J. 1983 Oct 15;216(1):71–80. doi: 10.1042/bj2160071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weisgraber K. H., Innerarity T. L., Mahley R. W. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 1982 Mar 10;257(5):2518–2521. [PubMed] [Google Scholar]
  41. Westerman J., Wirtz K. W. The primary structure of the nonspecific lipid transfer protein (sterol carrier protein 2) from bovine liver. Biochem Biophys Res Commun. 1985 Feb 28;127(1):333–338. doi: 10.1016/s0006-291x(85)80163-7. [DOI] [PubMed] [Google Scholar]
  42. Zilversmit D. B. Lipid transfer proteins. J Lipid Res. 1984 Dec 15;25(13):1563–1569. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES